Investors Are Taking Notice, Are You?
This company aims to provide the solution to early detection with their device. The device is a revolutionary, simple and effective technology that detects the potential for cardiovascular disease, even at its earliest stages.
Clinical trials have begun and the device has been approved for the FDA’s Expedited Access Pathway (EAP) program. Momentum is building and it has been trading hundreds of thousands in volume each day as investors are taking notice & we have the full details!